FDA Person
Office of Regulatory AffairsKristin M. Abaonza
View detailed information about Kristin M. Abaonza, including compliance records, violations, and related data.
Person Profile
Comprehensive profile of Kristin M. Abaonza, including their role, qualifications, and regulatory activities.
Recent Records (33)
Page 1 of 2RESUME - Unknown Company
RESUME
483 - White House Pharmacy Inc. dba San Jose Compounding Pharmacy
483
483 - Geneva Woods Pharmacy Inc
483
483 - Reliable Rexall-A Compounding Pharmacy
483
483 - One Way Drug, LLC
483
483 - Anish Shah, M.D.
483
EIR - Spectrum Laboratory Products, Inc.
EIR
483 - TriReme Medical, LLC.
483
483 - Santa Clara Valley Medical Center IRB
483
483 - LimFlow, Inc.
483
483 - BioEclipse Therapeutics, Inc.
483
483 - Kaiser Foundation Research Institute IRB #8
483
483 - Stanford University School of Medicine Radioactive Drug Research Committee
483
483 - Element Materials Technology Oakland-Concord
483
483 - Boehringer Ingelheim Fremont, Inc.
483
483 - Lykos Therapeutics, Inc.
483
483 - VitaSea Products Int'l , Inc. dba Wachters' Organic Sea Products
483
483 - Hessam Aazami, M.D.
483
483 - Neuralink Corporation
483
483 - Vanton Research Laboratory, LLC
483
Showing 1-20 of 33 records
Related People (5)
Related Office
Person Information
Name
Kristin M. Abaonza
Role
Regulatory Personnel
ID: cf909da8-837d-4dfe-9ccc-288b24d7bba3
Get More Insights
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox